Published: November 2011
Price: $ 6000
This analysis of the U.S. formalin fixed paraffin embedded (FFPE) sample prep market illuminates how the existing FFPE legacy in solid-tumor diagnostics is being transformed by advanced molecular techniques. Customer demand data collected by Frost & Sullivan provides the foundation for a market penetration model in which the relative growth stage of both the hospital and reference lab segments is determined. Furthermore, the adoption trend for FFPE sample prep automation is predicted by an install base forecast in clinical laboratories for 2011 to 2016. Companies that participate in the market include Qiagen, Life Technologies, and Roche Applied Sciences.
Browse All: Pharmaceuticals Market Research
Table of Contents
1. Executive Summary
Market Overview
Introduction
2. U.S. Cancer Sample Prep Market
Market Overview
Introduction
Scope and Segmentation
Research Methodology
Market Engineering Measurements
Industry Challenges and Strategic Recommendations
Industry Challenges
Strategic Recommendations
Market Drivers and Restraints
Market Drivers
Market Restraints
Demand Analysis
Market Penetration Model
Market Penetration Analysis
Installed Base Forecast
Revenue Forecast
Revenue Forecast Assumptions
Revenue Forecast Analysis
Competitive Structure
Competitive Structure
Product Analysis
Product Analysis
Voice-of-Customer Analysis
3. Appendix
Supplementary Data
Growth of FFPE Extraction Volume
Downstream Applications for FFPE Extractions
Reasons for Lab Send-Out of FFPE Extractions
Database of Cancer Research Centers
No comments:
Post a Comment